Transmitter exclusives: On 22 September, the Trump administration announced the launch of the Autism Data Science Initiative (ADSI) and a move to approve leucovorin (also known as folinic acid) as a treatment for autism-like symptoms in children with cerebral folate deficiency. In a multi-part exclusive, The Transmitter took a closer look at these decisions. Our reporters examine the […]
When the U.S. Food and Drug Administration (FDA) announced during a White House press conference last week that it would expand the use of leucovorin as “a promising treatment for symptoms of autism,” it cited an analysis of 23 publications. The Transmitter has obtained the list of the 23 studies—which together examine leucovorin treatment in […]
On 22 September, Richard Frye was in Saudi Arabia when he says he woke up to an email from Mehmet Oz, head of the U.S. Centers for Medicare & Medicaid Services, inviting him to the White House that afternoon. Although Frye was unable to attend, he soon learned that Oz’s boss, Health and Human Services […]
New labels: We’re closely following coverage tied to last week’s White House press conference about autism, in which U.S. federal administration officials announced plans to add warnings for pregnant people on acetaminophen (Tylenol) labels and to approve the supplement leucovorin for autism treatment. STAT reported on the “unreliable” testimony the Trump administration cited in asserting a […]
O n 22 September 2025, Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr. made several updates related to his pledge, made in May, to provide answers as to what has caused an apparent increase in autism prevalence in the United States over time. Kennedy stated that, in light of evidence showing an […]
